Technical Analysis for DXR - Daxor Corporation

Grade Last Price % Change Price Change
D 8.76 1.15% 0.10
DXR closed up 1.15 percent on Friday, November 1, 2024, on 1.92 times normal volume. It ran into resistance at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
200 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Bullish Engulfing Bullish 0.00%
Cup with Handle Other 0.00%
Outside Day Range Expansion 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish 1.15%
Cup with Handle Other 1.15%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 21 hours ago
200 DMA Resistance about 21 hours ago
50 DMA Resistance about 21 hours ago
20 DMA Resistance about 21 hours ago
10 DMA Resistance about 21 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Daxor Corporation Description

Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Disorders Hypertension Heart Failure Hematology Anemia Radiology Blood Transfusion Medicine Red Blood Cell Science Kidney Failure Blood Transfusion Medical Device Manufacturing Blood Volume Hematopathology Polycythemia Syncope

Is DXR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.03
52 Week Low 7.11
Average Volume 6,457
200-Day Moving Average 8.96
50-Day Moving Average 8.93
20-Day Moving Average 8.86
10-Day Moving Average 8.86
Average True Range 0.30
RSI (14) 47.09
ADX 14.91
+DI 35.97
-DI 18.30
Chandelier Exit (Long, 3 ATRs) 8.56
Chandelier Exit (Short, 3 ATRs) 9.41
Upper Bollinger Bands 9.22
Lower Bollinger Band 8.51
Percent B (%b) 0.35
BandWidth 7.96
MACD Line -0.06
MACD Signal Line -0.03
MACD Histogram -0.0234
Fundamentals Value
Market Cap 34.07 Million
Num Shares 3.89 Million
EPS 0.05
Price-to-Earnings (P/E) Ratio 165.28
Price-to-Sales 98.79
Price-to-Book 4.99
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.50
Resistance 3 (R3) 9.49 9.25 9.37
Resistance 2 (R2) 9.25 9.06 9.25 9.33
Resistance 1 (R1) 9.00 8.94 9.13 9.01 9.29
Pivot Point 8.76 8.76 8.82 8.76 8.76
Support 1 (S1) 8.51 8.57 8.64 8.52 8.23
Support 2 (S2) 8.27 8.45 8.27 8.19
Support 3 (S3) 8.02 8.27 8.15
Support 4 (S4) 8.03